Your browser doesn't support javascript.
loading
Human herpesvirus 8 can be transmitted through blood in drug addicts
Sosa, Carlos; Benetucci, Jorge; Hanna, Colleen; Sieczkowski, Laura; Deluchi, Gabriel; Canizal, Ana; Mantina, Hamakwa; Klaskala, Winslow; Baum, Mariana; Charles, Wood.
  • Sosa, Carlos; University of Nebraska. School of Biological Sciences. US
  • Benetucci, Jorge; Fundación de Ayuda al Inmunodeficiente (FUNDAI). Buenos Aires. AR
  • Hanna, Colleen; University of Nebraska. School of Biological Sciences. US
  • Sieczkowski, Laura; University of Nebraska. School of Biological Sciences. US
  • Deluchi, Gabriel; Fundación de Ayuda al Inmunodeficiente (FUNDAI). Buenos Aires. AR
  • Canizal, Ana; Fundación de Ayuda al Inmunodeficiente (FUNDAI). Buenos Aires. AR
  • Mantina, Hamakwa; University of Nebraska. School of Biological Sciences. US
  • Klaskala, Winslow; University of Miami School of Medicine. Forgaty International Center. Miami. US
  • Baum, Mariana; University of Miami School of Medicine. Forgaty International Center. Miami. US
  • Charles, Wood; University of Nebraska. School of Biological Sciences. US
Medicina (B.Aires) ; 61(3): 291-294, 2001. tab
Article in English | LILACS | ID: lil-290124
RESUMO
Human Herpes virus type-8 (HHV-8) seroprevalence was studied in a population of HIV positive intravenous drug users (IVDUs) from Argentina. Analysis of this population also indirectly made it possible to study HHV-8 blood transmission, because these individuals frequently engage in needle sharing behavior and are capable of acquiring a broad array of blood borne pathogens, including Hepatitis B/C virus. The seroprevalence of HHV-8 in IVDUs was compared to a group of non-IVDUs and HIV negative individuals. Of the 223 individuals tested, 13.45 percent were HHV-8 positive, 16.99 percent in the IVDUs group, and 5.71 percent in the non-IVDUs. Among HIV positive IVDUs, 25/144 (17.36 percent) were also HHV-8 seropositive. The seropositivity rate of HHV-8 in HIV negative IVDUs was 11.1 percent. In contrast, HHV-8 seroprevalence in HIV negative heterosexual individuals without drug usage behavior was even lower (5.71 percent). The rate of HHV-8 infection in HIV positive IVDUs was three times as high compared to the non IVDU HIV negative individuals, suggesting that IVDU is a risk for HHV-8 infection. Furthermore, it was found that IVDUs showed a very high rate of Hepatitis B/C (52.77 percent), which also correlate with HHV-8 infection in this population (23.68 percent). All Hepatitis B/C positive individuals were also HIV positive. Our data confirm other studies showing that individuals who share needles are at risk for acquiring Hepatitis B/C and HIV infections. In addition, our results suggest that they are also at risk to acquiring HHV-8 infection by the same route.
Subject(s)
Full text: Available Index: LILACS (Americas) Main subject: HIV Infections / Substance Abuse, Intravenous / Needle Sharing / Herpesviridae Infections / Herpesvirus 8, Human Type of study: Diagnostic study / Etiology study / Observational study / Risk factors Limits: Adult / Female / Humans / Male Country/Region as subject: South America / Argentina Language: English Journal: Medicina (B.Aires) Journal subject: Medicine Year: 2001 Type: Article Affiliation country: Argentina / United States Institution/Affiliation country: Fundación de Ayuda al Inmunodeficiente (FUNDAI)/AR / University of Miami School of Medicine/US / University of Nebraska/US

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: LILACS (Americas) Main subject: HIV Infections / Substance Abuse, Intravenous / Needle Sharing / Herpesviridae Infections / Herpesvirus 8, Human Type of study: Diagnostic study / Etiology study / Observational study / Risk factors Limits: Adult / Female / Humans / Male Country/Region as subject: South America / Argentina Language: English Journal: Medicina (B.Aires) Journal subject: Medicine Year: 2001 Type: Article Affiliation country: Argentina / United States Institution/Affiliation country: Fundación de Ayuda al Inmunodeficiente (FUNDAI)/AR / University of Miami School of Medicine/US / University of Nebraska/US